The annual numbers trace the cycle directly. From revenue of KRW 1,090.9bn and operating profit of KRW 207.1bn (19.0% margin) in 2022, results fell to KRW 844.0bn and KRW 133.5bn (15.8%) in 2023, then margins recovered in 2024 on revenue of KRW 863.4bn and operating profit of KRW 167.9bn (19.5%).
In 2025, however, revenue rose to KRW 923.4bn while operating profit fell to KRW 133.6bn (14.5%), so the top line grew as profit shrank.
The Korea IR Council pointed to initial one-off costs from the Sun Fluoro System acquisition, higher SG&A and spending on the new glass substrate pilot line as reasons for the margin decline.
Net profit attributable to owners also fell from KRW 118.4bn in 2024 to KRW 79.1bn in 2025, and in 4Q25 the gap was stark, with operating profit of KRW 43.0bn against owners' net profit of KRW 10.7bn.
The quarterly trend is clearer in direction: revenue rose for five straight quarters, from KRW 228.8bn in 2Q25 to KRW 241.1bn, KRW 244.0bn, KRW 263.8bn and KRW 312.0bn, with operating profit climbing from KRW 20.2bn to KRW 34.4bn, KRW 43.0bn, KRW 44.7bn and KRW 46.0bn.
The operating margin, though, slipped from 16.9% in 1Q26 to 14.7% in 2Q26, and Meritz Securities said logistics disruption tied to Middle East conflict pushed up prices for raw materials such as hydrofluoric acid, that the company is negotiating price increases on key products including etchants, and that the effect should appear from the third quarter.
Owners' net profit of KRW 54.8bn in 2Q26 exceeded that quarter's operating profit, a result of non-operating items rather than a pattern that can be assumed to repeat each quarter.
On the balance sheet, total liabilities rose from KRW 76.6bn in 2023 to KRW 335.2bn in 2025 and the debt-to-equity ratio from 8.3% to 30.2%, non-controlling interests grew from KRW 29.0bn to KRW 55.8bn as consolidation widened, and operating cash flow narrowed from KRW 262.3bn in 2024 to KRW 146.9bn in 2025.